An approach to the patient with retiform purpura

2011 ◽  
Vol 24 (2) ◽  
pp. 151-172 ◽  
Author(s):  
Ashley Wysong ◽  
Priya Venkatesan
Keyword(s):  
Retiform Purpura

Retiform Purpura—Quiz Case

2003 ◽  
Vol 139 (6) ◽  
Author(s):  
Marlyanne M. Pol-Rodriguez ◽  
Saara Crane ◽  
Dennis L. Feinberg ◽  
Earl J. Glusac ◽  
Jean L. Bolognia
Keyword(s):  
Retiform Purpura

27736 Painful retiform purpura with cutaneous necrosis

2021 ◽  
Vol 85 (3) ◽  
pp. AB160
Author(s):  
Alfredo Siller ◽  
Joseph Jebain ◽  
Yomna Amer ◽  
Christopher T. Haley ◽  
Leon Chen ◽  
...  
Keyword(s):  
Cutaneous Necrosis ◽  
Retiform Purpura

scholarly journals Concomitant calciphylaxis and COVID-19 associated thrombotic retiform purpura

2020 ◽  
Vol 49 (11) ◽  
pp. 1879-1884 ◽  
Author(s):  
Jessica A. Rotman ◽  
Kathryn E. Dean ◽  
Cynthia Magro ◽  
Gerard Nuovo ◽  
Roger J. Bartolotta
Keyword(s):  
Retiform Purpura

Cocaine-associated retiform purpura and neutropenia: Is levamisole the culprit?

2010 ◽  
Vol 63 (3) ◽  
pp. 530-535 ◽  
Author(s):  
Jeanette M. Waller ◽  
Jamison D. Feramisco ◽  
Lauren Alberta-Wszolek ◽  
Timothy H. McCalmont ◽  
Lindy P. Fox
Keyword(s):  
Retiform Purpura

scholarly journals Retiform Purpura in Plaques

2015 ◽  
Vol 106 (10) ◽  
pp. 831-832
Author(s):  
G. Márquez Balbás ◽  
A. Vidaller ◽  
F. Tresserra-Casas ◽  
J. González-Castro
Keyword(s):  
Retiform Purpura

scholarly journals Retiform Purpura in the Setting of COVID-19: A Harbinger of Underlying Coagulopathy and Severe Disease Course

2021 ◽  
Vol 5 (4) ◽  
pp. 434-436
Author(s):  
Gabrielle Brody ◽  
Michael O. Nguyen ◽  
Delila Pouldar Foulad ◽  
Nathan W. Rojek
Keyword(s):  
Current Literature ◽  
Symptom Onset ◽  
Severe Disease ◽  
Outpatient Setting ◽  
Clinical Deterioration ◽  
Cutaneous Manifestation ◽  
Disease Course ◽  
Clinical Challenge ◽  
Retiform Purpura

While the majority of COVID-19 cases are mild and can be managed in the outpatient setting, more severe cases have proven to be a clinical challenge. While some cases demonstrate a more slow and indolent decline, others seem to deteriorate rapidly with little forewarning. The current literature has connected Retiform Purpura as a cutaneous manifestation associated with severe COVID-19 infections, however timing of cutaneous presentation and severe clinical COVID-19 symptoms has not been well described. Here we report a case of a 58-year-old female who developed Retiform Purpura nearly a week prior to the development of any significant COVID-19 symptoms. This case demonstrates that Retiform Purpura is not only associated with severe COVID-19 disease, but can present prior to symptom onset and should be seen as a harbinger for impending clinical deterioration.

scholarly journals Generalized retiform purpura as a presenting sign of diffuse dermal angiomatosis

2018 ◽  
Vol 24 (5) ◽  
Author(s):  
Tanya Bhattacharya ◽  
Jason Sluzevich
Keyword(s):  
Retiform Purpura
Sign in / Sign up

Export Citation Format

Share Document